GPRC5A and adrenal cortex carcinoma: Strikingly, when we evaluated the twenty enriched MET genes for their prognostic value in ACC patient outcome, expression of two genes—PPL (a structural component of desmosomes) and GPRC5A (a G protein-coupled receptor with an unidentified endogenous ligand)—were found to be associated with increased patient survival.